Abiomed (GB:0H7S)

Abiomed (0H7S) Cash flow


Abiomed Cash Flow

GB:0H7S's free cash flow for Q was $7.81M. For the fiscal year, GB:0H7S's free cash flow was decreased by $28.43M and operating cash flow was $13.42M. See a summary of the company’s cash flow.
Cash Flow
Mar 22Mar 21Mar 20Mar 19Mar 18
Operating Cash Flow
$ 250.98M$ 285.39M$ 274.58M$ 314.92M$ 252.20M$ 192.55M
Investing Cash Flow
$ -162.91M$ -380.99M$ -223.34M$ -125.45M$ -116.45M$ -180.76M
Financing Cash Flow
$ -135.53M$ -2.20M$ -8.07M$ -117.72M$ -55.77M$ -9.14M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 639.90M$ 132.82M$ 232.71M$ 192.34M$ 121.02M$ 42.98M
Income Tax Paid Supplemental Data
$ 94.73M$ 61.76M$ 48.69M$ 9.69M$ 5.29M$ 4.64M
Interest Paid Supplemental Data
---$ 0.00$ 0.00$ 302.00K
Issuance Of Capital Stock
Issuance Of Debt
Repayment Of Debt
---$ 0.00$ 0.00$ -517.00K
Free Cash Flow
$ 217.22M$ 249.63M$ 221.19M$ 270.91M$ 208.19M$ 136.68M
Domestic Sales
Foreign Sales
Currency in USD

Abiomed Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis